HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Val J Watts Selected Research

2,3- dihydroxy- 6a,7,8,12b- tetrahydro- 6H- chromeno(3,4- c)isoquinoline

7/2012Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Val J Watts Research Topics

Disease

4Pain (Aches)
01/2022 - 02/2015
4Chronic Pain
01/2022 - 01/2018
4Yellow Fever
03/2015 - 01/2012
3Whooping Cough (Pertussis)
01/2018 - 08/2015
3Parkinson Disease (Parkinson's Disease)
03/2015 - 07/2012
2Anthrax
01/2018 - 11/2016
2Schizophrenia (Dementia Praecox)
03/2015 - 01/2015
2Lyme Disease (Disease, Lyme)
11/2012 - 08/2011
2Central Nervous System Diseases (CNS Diseases)
01/2012 - 04/2007
1Hyperalgesia
01/2021
1Toxemia
01/2018
1Neglected Diseases
03/2015
1Filarial Elephantiasis (Lymphatic Filariasis)
03/2015
1Nervous System Diseases (Neurological Disorders)
01/2014
1Substance-Related Disorders (Drug Abuse)
01/2014
1Vector Borne Diseases
01/2012
1Animal Diseases
08/2011
1Body Weight (Weight, Body)
09/2006
1Neuroblastoma
01/2004
1Mental Disorders (Mental Disorder)
10/2003

Drug/Important Bio-Agent (IBA)

7Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2022 - 01/2004
7Dopamine Receptors (Dopamine Receptor)IBA
03/2015 - 01/2004
2Pharmaceutical PreparationsIBA
01/2022 - 03/2015
2Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2022 - 01/2019
2Opioid Analgesics (Opioids)IBA
01/2021 - 01/2018
2Ethanol (Ethyl Alcohol)IBA
01/2021 - 01/2018
2Virulence Factors (Pathogenicity Factors)IBA
01/2018 - 11/2016
2edema factorIBA
01/2018 - 11/2016
2Adenylate Cyclase ToxinIBA
01/2018 - 11/2016
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
03/2015 - 01/2015
2Antipsychotic Agents (Antipsychotics)IBA
01/2015 - 01/2015
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2015 - 08/2011
2Dopamine AntagonistsIBA
11/2012 - 01/2012
2Dopamine (Intropin)FDA LinkGeneric
11/2012 - 07/2012
2Neurotransmitter Agents (Neurotransmitter)IBA
08/2011 - 10/2003
1PyrimidinonesIBA
01/2022
1adenylyl cyclase 1IBA
01/2022
1pevonedistatIBA
01/2021
1Cocaine (Cocaine HCl)IBA
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2019
11,3,4-oxadiazoleIBA
01/2019
1NucleosidesIBA
08/2015
1Organophosphonates (Phosphonates)IBA
08/2015
1InsecticidesIBA
03/2015
1PesticidesIBA
03/2015
1Adenylyl Cyclase InhibitorsIBA
02/2015
1Aripiprazole (Abilify)FDA Link
01/2015
1Antidepressive Agents (Antidepressants)IBA
01/2015
1Oxidopamine (6 Hydroxydopamine)IBA
07/2012
1dihydrexidineIBA
07/2012
12,3- dihydroxy- 6a,7,8,12b- tetrahydro- 6H- chromeno(3,4- c)isoquinolineIBA
07/2012
1AcaricidesIBA
08/2011
1Protein Isoforms (Isoforms)IBA
04/2007
1QuinpiroleIBA
09/2006
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2004

Therapy/Procedure

1Therapeutics
03/2015
1Injections
09/2006